References
- 1. Bryers JD. Medical biofilms. Biotechnology and Bioengineering. 2008;100:1-18.10.1002/bit.21838270631218366134
- 2. Michel V, Doi Y, Hellwich K, et al. Terminology for biorelated polymers and applications (IUPAC Recommendations 2012). Pure and Applied Chemistry. 2012;8:377-410.10.1351/PAC-REC-10-12-04
- 3. Hall-Stoodley L, Costerton JW, Stoodley P. Bacterial biofilms: from the natural environment to infectious diseases. Nature Reviews Microbiology. 2004;2:95-108.10.1038/nrmicro82115040259
- 4. Wu H, Moser C, Wang HZ, et al. Strategies for combating bacterial biofilm infections. Int J Oral Sci. 2015;23;7:1-7.10.1038/ijos.2014.65481753325504208
- 5. Auler ME, Morreira D, Rodrigues FF, et al. Biofilm formation on intrauterine devices in patients with recurrent vulvovaginal candidiasis. Medical Mycology. 2009;48:211-216.10.3109/1369378090285662620055746
- 6. Ciofu O, Rojo-Molinero E, Macià MD, et al. Antibiotic treatment of biofilm infections. APMIS. 2017;125:304-319.10.1111/apm.1267328407419
- 7. Rabin N, Zheng Y, Opoku-Temeng C, et al. Agents that inhibit bacterial biofilm formation. Future Med Chem. 2015;7:647-671.10.4155/fmc.15.725921403
- 8. Worlitzsch D, Tarran R, Ulrich M, et al. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest. 2002;109:317-325.10.1172/JCI0213870
- 9. Jensen PO, Briales A, Brochmann RP, et al. Formation of hydroxyl radicals contributes to the bactericidal activity of ciprofloxacin against Pseudomonas aeruginosa biofilms. Pathog Dis. 2014;70:440-443.10.1111/2049-632X.1212024376174
- 10. Cao B, Christophersen L, Thomsen K, et al. Antibiotic penetration and bacterial killing in a Pseudomonas aeruginosa biofilm model. J Antimicrob Chemother. 2015;70:2057-2063.10.1093/jac/dkv05825786481
- 11. Kadurugamuwa JL, Sin L, Albert E, et al. Direct continuous method for monitoring biofilm infection in a mouse model. Infect Immun. 2003;71:882-890.10.1128/IAI.71.2.882-890.200314536212540570
- 12. Rupp ME, Ulphani JS, Fey PD, et al. Characterization of the importance of polysaccharide intercellular adhesin/hemagglutinin of Staphylococcus epidermidis in the pathogenesis of biomaterial-based infection in a mouse foreign body infection model. Infect Immun. 1999;67:2627-2632.10.1128/IAI.67.5.2627-2632.199911601510225932
- 13. Hirano L, Bayer AS. Beta-Lactam-beta-lactamase-inhibitor combinations are active in experimental endocarditis caused by beta-lactamase-producing oxacillin-resistant staphylococci. Antimicrob Agents Chemother. 1991;35:685-690.10.1128/AAC.35.4.6852450792069374
- 14. Roche ED, Renick PJ, Tetens SP, et al. Increasing the presence of biofilm and healing delay in a porcine model of MRSA-infected wounds. Wound Repair Regen. 2012;20:537-543.10.1111/j.1524-475X.2012.00808.x22672311
- 15. Johansen HK, Høiby N. Novel mouse model of chronic Pseudomonas aeruginosa lung infection mimicking cystic fibrosis. Infect Immun. 2005;73:2504-2514.10.1128/IAI.73.4.2504-2514.2005108739915784597
- 16. de Lima Pimenta A, Chiaradia-Delatorre LD, Mascarello A, et al. Synthetic organic compounds with potential for bacterial biofilm inhibition, a path for the identification of compounds interfering with quorum sensing. Int J Antimicrob Agents. 2013;42:519-523.10.1016/j.ijantimicag.2013.07.00624016798
- 17. Balaban N, Cirioni O, Giacometti A, et al. Treatment of Staphylococcus aureus biofilm infection by the quorum-sensing inhibitor RIP. Antimicrob Agents Chemother. 2007;51:2226-2229.10.1128/AAC.01097-06189138317371825
- 18. Francolini I, Norris P, Piozzi A, et al. Usnic acid, a natural antimicrobial agent able to inhibit bacterial biofilm formation on polymer surfaces. Antimicrob Agents Chemother. 2004;48:4360-4365.10.1128/AAC.48.11.4360-4365.200452540515504865
- 19. Rasamiravaka T, Labtani Q, Duez P, et al. The formation of biofilms by Pseudomonas aeruginosa: a review of the natural and synthetic compounds interfering with control mechanisms. Biomed Res Int. 2015:759348.10.1155/2015/759348438329825866808
- 20. Rasmussen TB, Skindersoe ME, Bjarnsholt T, et al. Identity and effects of quorum-sensing inhibitors produced by Penicillium species. Microbiology. 2005;151:1325-1340.10.1099/mic.0.27715-015870443
- 21. Roy V, Meyer MT, Smith JA, et al. AI-2 analogs and antibiotics: a synergistic approach to reduce bacterial biofilms. Appl Microbiol Biotechnol. 2013;97:2627-2638.10.1007/s00253-012-4404-623053069
- 22. Brackman G, Cos P, Maes L, et al. Quorum sensing inhibitors increase the susceptibility of bacterial biofilms to antibiotics in vitro and in vivo. Antimicrob Agents Chemother. 2001;55:2655-2661.10.1128/AAC.00045-11310140921422204
- 23. Zeng X, Liu X, Bian J, et al. Synergistic effect of 14-alpha-lipoyl andrographolide and various antibiotics on the formation of biofilms and production of exopolysaccharide and pyocyanin by Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2011;55:3015-3017.10.1128/AAC.00575-10310138821422201
- 24. Jakobsen TH, van Gennip M, Phipps RK, et al. Ajoene, a sulfur-rich molecule from garlic, inhibits genes controlled by quorum sensing. Antimicrob Agents Chemother. 2012;56:2314-2325.10.1128/AAC.05919-11334666922314537
- 25. Yang JY, Della-Fera MA, Nelson-Dooley C, et al. Molecular mechanisms of apoptosis induced by ajoene in 3T3-L1 adipocytes. Obesity. 2006;14:388-397.10.1038/oby.2006.5216648609
- 26. Jakobsen TH, Warming AN, Vejborg RM, et al. A broad range quorum sensing inhibitor working through sRNA inhibition. Sci Rep. 2017;7:9857.10.1038/s41598-017-09886-8557534628851971
- 27. Rendueles O, Kaplan JB, Ghigo JM. Antibiofilm polysaccharides. Environmental Microbiol. 2013;15:334-346.10.1111/j.1462-2920.2012.02810.x350268122730907
- 28. Roy R, Tiwari M, Donelli G, et al. Strategies for combating bacterial biofilms: A focus on anti-biofilm agents and their mechanisms of action. Virulence. 2018;9:522-554.10.1080/21505594.2017.1313372595547228362216
- 29. Durig A, Kouskoumvekaki I, Vejborg RM, et al. Chemoinformatics-assisted development of new anti-biofilm compounds. Applied Microbiol Biotechnol. 2010;87:309-317.10.1007/s00253-010-2471-020204615
- 30. Ojha AK, Baughn AD, Sambandan D, et al. Growth of Mycobacterium tuberculosis biofilms containing free mycolic acids and harbouring drug-tolerant bacteria. Mol Microbiol. 2008;69:164-174.10.1111/j.1365-2958.2008.06274.x261518918466296
- 31. Artini M, Romano C, Manzoli L, et al. Staphylococcal IgM ELISA for the detection of periprosthetic joint infections. J Clin Microbiol. 2011;49:423-425.10.1128/JCM.01836-10302041521068292